Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
RS McIntyre, L Phan, ATH Kwan, RB Mansur… - Brain, 2024 - academic.oup.com
Hitherto no therapeutic has received regulatory approval for the treatment of post-COVID-19
condition (PCC). Cognitive deficits, mood symptoms and significant reduction in health …
condition (PCC). Cognitive deficits, mood symptoms and significant reduction in health …
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine
A Cuomo, A Aguglia, D De Berardis… - Annals of General …, 2024 - Springer
Background Depression is a highly heterogeneous disorder, often resulting in suboptimal
response and remission rates. This underscores the need for more nuanced clinical …
response and remission rates. This underscores the need for more nuanced clinical …
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder
A Cuomo, G Barillà, M Cattolico… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Major Depressive Disorder (MDD) is a mental health issue that
significantly affects patients' quality of life and functioning. Despite available treatments …
significantly affects patients' quality of life and functioning. Despite available treatments …
Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study
G Wang, T Si, A Rieckmann, J Ma… - Neuropsychiatric …, 2024 - Taylor & Francis
Background Major depressive disorder (MDD) causes significant functional impairments that
impact on all aspects of patients' daily lives, including their ability to work, work productivity …
impact on all aspects of patients' daily lives, including their ability to work, work productivity …
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets
A Fagiolini, M Adair… - Journal of …, 2024 - journals.sagepub.com
Background: Vortioxetine is efficacious and well tolerated in patients with major depressive
disorder (MDD) and is available as an immediate-release tablet and oral drop solution. The …
disorder (MDD) and is available as an immediate-release tablet and oral drop solution. The …